Header Logo
Keywords
Last Name
Institution
Announcement

You can now add alternative names! Click here to add other names that you've published under.

Mulu Tesfay

Concepts (77)

Concept scores are derived automatically based on a person's publications. Keywords in the their attributed publications are matched to keywords from the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). The strength of a person's concept scores is based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the topic.Concepts cannot be directly edited. You can help ensure your concepts are accurate by making sure your attributed publications are correct and up-to-date. We recommend checking over your attributed publications list every three to four months.

Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Tumor Microenvironment
4
2026
274
1.690
Why?
Oncolytic Virotherapy
4
2026
28
1.640
Why?
Carcinoma, Pancreatic Ductal
2
2026
43
1.120
Why?
Immunotherapy
2
2026
266
1.010
Why?
Pancreatic Neoplasms
2
2026
219
0.970
Why?
Isoantigens
1
2026
15
0.950
Why?
Carcinoma, Hepatocellular
1
2025
213
0.760
Why?
Liver Neoplasms
1
2025
347
0.700
Why?
Cell Line, Tumor
3
2026
1470
0.420
Why?
Vesiculovirus
1
2014
6
0.420
Why?
Complement System Proteins
1
2014
32
0.410
Why?
Immunoglobulin M
1
2014
59
0.400
Why?
Vesicular stomatitis Indiana virus
1
2013
2
0.380
Why?
Viremia
1
2013
23
0.380
Why?
Interferon-beta
3
2013
32
0.380
Why?
Polyethylene Glycols
1
2013
95
0.360
Why?
Animals
7
2026
13528
0.280
Why?
Mice
4
2026
5982
0.280
Why?
Interferon-alpha
2
2008
53
0.280
Why?
RNA Caps
1
2007
5
0.270
Why?
eIF-2 Kinase
1
2007
12
0.270
Why?
Protein Biosynthesis
2
2008
268
0.240
Why?
CTLA-4 Antigen
1
2025
32
0.230
Why?
Oncolytic Viruses
1
2025
13
0.230
Why?
Programmed Cell Death 1 Receptor
1
2025
46
0.230
Why?
Lymphocytes, Tumor-Infiltrating
1
2025
89
0.220
Why?
CD8-Positive T-Lymphocytes
1
2025
145
0.210
Why?
RNA, Messenger
1
2007
1133
0.210
Why?
Neutralization Tests
2
2014
26
0.200
Why?
Vero Cells
2
2014
40
0.200
Why?
Green Fluorescent Proteins
2
2014
85
0.200
Why?
DNA Primers
2
2014
202
0.190
Why?
Disease Models, Animal
1
2025
1517
0.160
Why?
Mice, Inbred C57BL
1
2025
1925
0.160
Why?
Community-Acquired Infections
1
2019
42
0.140
Why?
Multiple Myeloma
1
2013
3082
0.140
Why?
Humans
7
2026
53246
0.140
Why?
Pneumonia
1
2019
123
0.130
Why?
Radiography
1
2019
476
0.130
Why?
Radiology
1
2019
137
0.130
Why?
Neoplasms
1
2025
1335
0.110
Why?
Viral Envelope Proteins
1
2014
31
0.100
Why?
HEK293 Cells
1
2014
235
0.100
Why?
Chromatography
1
2013
11
0.100
Why?
Real-Time Polymerase Chain Reaction
1
2013
181
0.090
Why?
Drug Discovery
1
2013
94
0.090
Why?
Kaplan-Meier Estimate
1
2013
487
0.090
Why?
Cricetinae
2
2008
190
0.080
Why?
Antibodies, Monoclonal
1
2014
477
0.080
Why?
Encephalitis Virus, Venezuelan Equine
1
2008
1
0.070
Why?
Encephalitis Virus, Eastern Equine
1
2008
3
0.070
Why?
Cell Line
2
2008
1016
0.070
Why?
Dendritic Cells
1
2008
133
0.070
Why?
Female
2
2026
28792
0.060
Why?
Reverse Transcriptase Polymerase Chain Reaction
1
2007
579
0.060
Why?
Blotting, Western
1
2007
587
0.060
Why?
Macrophages
1
2008
380
0.060
Why?
Genetic Engineering
1
2025
24
0.060
Why?
Immunomodulation
1
2024
36
0.050
Why?
Combined Modality Therapy
1
2025
640
0.050
Why?
Signal Transduction
1
2024
1748
0.030
Why?
Severity of Illness Index
1
2019
1049
0.030
Why?
Emergency Service, Hospital
1
2019
530
0.030
Why?
Cohort Studies
1
2019
1557
0.030
Why?
Prospective Studies
1
2019
2412
0.020
Why?
Infant
1
2019
3808
0.020
Why?
Child, Preschool
1
2019
4164
0.020
Why?
Encephalomyelitis, Venezuelan Equine
1
2008
1
0.020
Why?
Encephalomyelitis, Equine
1
2008
3
0.020
Why?
Adolescent
1
2019
6912
0.020
Why?
Viral Proteins
1
2008
164
0.020
Why?
Survival Analysis
1
2008
659
0.020
Why?
Fibroblasts
1
2008
363
0.020
Why?
Child
1
2019
7384
0.010
Why?
Osteoblasts
1
2008
480
0.010
Why?
Cells, Cultured
1
2008
1569
0.010
Why?
Male
1
2019
27444
0.010
Why?
Tesfay's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
_
Co-Authors Expand Description
_
Similar People Expand Description
_
Same Department Expand Description